世界の髄核置換装置市場:医療機器パイプライン分析2016

◆英語タイトル:Nucleus Replacement - Medical Devices Pipeline Assessment, 2016
◆商品コード:GDME0200EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年6月1日
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥555,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥832,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、髄核置換装置のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・髄核置換装置の概要
・髄核置換装置の開発動向:開発段階別分析
・髄核置換装置の開発動向:セグメント別分析
・髄核置換装置の開発動向:領域別分析
・髄核置換装置の開発動向:規制Path別分析
・髄核置換装置の開発動向:承認日(推定)別分析
・企業別髄核置換装置の開発動向(パイプライン製品、進行中の治験)
・髄核置換装置の最近動向
【レポートの概要】

Nucleus Replacement – Medical Devices Pipeline Assessment, 2016

Summary

GlobalData’s Medical Devices sector report, “Nucleus Replacement – Medical Devices Pipeline Assessment, 2016″ provides an overview of Nucleus Replacement currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Nucleus Replacement pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Nucleus Replacement under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Nucleus Replacement and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Nucleus Replacement under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Nucleus Replacement Overview 6
3 Products under Development 7
3.1 Nucleus Replacement – Pipeline Products by Stage of Development 7
3.2 Nucleus Replacement – Pipeline Products by Territory 8
3.3 Nucleus Replacement – Pipeline Products by Regulatory Path 9
3.4 Nucleus Replacement – Pipeline Products by Estimated Approval Date 10
3.5 Nucleus Replacement – Ongoing Clinical Trials 11
4 Nucleus Replacement – Pipeline Products under Development by Companies 12
4.1 Nucleus Replacement Companies – Pipeline Products by Stage of Development 12
4.2 Nucleus Replacement – Pipeline Products by Stage of Development 13
5 Nucleus Replacement Companies and Product Overview 14
5.1 Arthro Kinetics AG Company Overview 14
5.1.1 Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Chi2Gel Ltd. Company Overview 15
5.2.1 Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Clariance SAS Company Overview 16
5.3.1 Clariance SAS Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 CryoLife, Inc. Company Overview 17
5.4.1 CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
5.5 Gentis Inc. Company Overview 19
5.5.1 Gentis Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
5.6 Hydrospine, Inc. Company Overview 22
5.6.1 Hydrospine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
5.7 Raymedica, LLC Company Overview 23
5.7.1 Raymedica, LLC Pipeline Products & Ongoing Clinical Trials Overview 23
5.8 Replication Medical, Inc. Company Overview 25
5.8.1 Replication Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.9 Spinalcyte Llc Company Overview 26
5.9.1 Spinalcyte Llc Pipeline Products & Ongoing Clinical Trials Overview 26
5.10 Spine Wave, Inc. Company Overview 27
5.10.1 Spine Wave, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.11 Stryker Corporation Company Overview 29
5.11.1 Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview 29
5.12 Synthes, Inc. Company Overview 31
5.12.1 Synthes, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.13 TranS1 Inc Company Overview 32
5.13.1 TranS1 Inc Pipeline Products & Ongoing Clinical Trials Overview 32
5.14 Vertebral Technologies, Inc. Company Overview 35
5.14.1 Vertebral Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.15 Zimmer Biomet Holdings, Inc. Company Overview 38
5.15.1 Zimmer Biomet Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
6 Nucleus Replacement- Recent Developments 40
6.1 May 04, 2016: SpinalCyte Receives New United States Patent for Spinal Disc Tissue Engineering 40
6.2 Apr 22, 2016: SpinalCyte Receives New Canadian Patent for Spinal Disc Tissue Engineering 40
6.3 Apr 19, 2016: SpinalCyte Announces Final Results From Phase II Animal Trials Using Human Dermal Fibroblast Transplantation for Intervertebral Disc Degeneration 40
6.4 Mar 29, 2016: SpinalCyte Announces New Results from Phase II Animal Trials of Cell Therapy to Regenerate the Spinal Disc 41
7 Appendix 42
7.1 Methodology 42
7.2 About GlobalData 45
7.3 Contact Us 45
7.4 Disclaimer 45

1.1 List of Tables
Table 1: Nucleus Replacement - Pipeline Products by Stage of Development 7
Table 2: Nucleus Replacement - Pipeline Products by Territory 8
Table 3: Nucleus Replacement - Pipeline Products by Regulatory Path 9
Table 4: Nucleus Replacement - Pipeline Products by Estimated Approval Date 10
Table 5: Nucleus Replacement - Ongoing Clinical Trials 11
Table 6: Nucleus Replacement Companies - Pipeline Products by Stage of Development 12
Table 7: Nucleus Replacement - Pipeline Products by Stage of Development 13
Table 8: Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 14
Table 9: NuReS - Product Status 14
Table 10: NuReS - Product Description 14
Table 11: Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 15
Table 12: Chi2Disc - Product Status 15
Table 13: Chi2Disc - Product Description 15
Table 14: Clariance SAS Pipeline Products & Ongoing Clinical Trials Overview 16
Table 15: NucleoFill - Product Status 16
Table 16: NucleoFill - Product Description 16
Table 17: CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
Table 18: Biodisc Nucleus Pulposus Replacement - Product Status 17
Table 19: Biodisc Nucleus Pulposus Replacement - Product Description 18
Table 20: Gentis Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
Table 21: DiscCell - Product Status 19
Table 22: DiscCell - Product Description 19
Table 23: Gentis Inc. - Ongoing Clinical Trials Overview 20
Table 24: DiscCell - Pivotal Clinical Study Of DiscCell Augmentation Versus Microdiscectomy 21
Table 25: Hydrospine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
Table 26: Intervertebral Disc Repair System - Product Status 22
Table 27: Intervertebral Disc Repair System - Product Description 22
Table 28: Raymedica, LLC Pipeline Products & Ongoing Clinical Trials Overview 23
Table 29: HydraFlex Nucleus Arthroplasty System - Product Status 23
Table 30: HydraFlex Nucleus Arthroplasty System - Product Description 24
Table 31: PDN-SOLO XL - Product Status 24
Table 32: PDN-SOLO XL - Product Description 24
Table 33: Replication Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
Table 34: NeuDisc - Product Status 25
Table 35: NeuDisc - Product Description 25
Table 36: Spinalcyte Llc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 37: Spinal Disc Tissue Regenerator - Product Status 26
Table 38: Spinal Disc Tissue Regenerator - Product Description 26
Table 39: Spine Wave, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
Table 40: NuCore Injectable Nucleus - Product Status 27
Table 41: NuCore Injectable Nucleus - Product Description 28
Table 42: NuCore RPXL Injectable Nucleus - Product Status 28
Table 43: NuCore RPXL Injectable Nucleus - Product Description 28
Table 44: Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview 29
Table 45: Aquarelle - Product Status 29
Table 46: Aquarelle - Product Description 30
Table 47: Synthes, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
Table 48: Hydrafil - Product Status 31
Table 49: Hydrafil - Product Description 31
Table 50: TranS1 Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 51: Percutaneous Nucleus Replacement - Product Status 32
Table 52: Percutaneous Nucleus Replacement - Product Description 32
Table 53: TranS1 Inc - Ongoing Clinical Trials Overview 33
Table 54: Percutaneous Nucleus Replacement - Feasibility Study To Assess The Safety And Effectiveness Of The PNR 34
Table 55: Vertebral Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
Table 56: InterCushion Disc Nucleus Replacement System - Product Status 35
Table 57: InterCushion Disc Nucleus Replacement System - Product Description 35
Table 58: Vertebral Technologies, Inc. - Ongoing Clinical Trials Overview 36
Table 59: InterCushion Disc Nucleus Replacement System - A Pilot Clinical Study to Assess the Safety and Effectiveness of the InterCushion Disc Nucleus Prosthesis in Patients Receiving Discectomy 37
Table 60: Zimmer Biomet Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
Table 61: Newcleus - Product Status 38
Table 62: Newcleus - Product Description 38
Table 63: Regain Lumbar Artificial Disc - Product Status 39
Table 64: Regain Lumbar Artificial Disc - Product Description 39
Table 65: Glossary 43

1.2 List of Figures
Figure 1: Nucleus Replacement - Pipeline Products by Stage of Development 7
Figure 2: Nucleus Replacement - Pipeline Products by Territory 8
Figure 3: Nucleus Replacement - Pipeline Products by Regulatory Path 9
Figure 4: Nucleus Replacement - Pipeline Products by Estimated Approval Date 10
Figure 5: Nucleus Replacement - Ongoing Clinical Trials 11

【掲載企業】

Arthro Kinetics AG
Chi2Gel Ltd.
Clariance SAS
CryoLife, Inc.
Gentis Inc.
Hydrospine, Inc.
Raymedica, LLC
Replication Medical, Inc.
Spinalcyte Llc
Spine Wave, Inc.
Stryker Corporation
Synthes, Inc.
TranS1 Inc
Vertebral Technologies, Inc.
Zimmer Biomet Holdings, Inc.

★調査レポート[世界の髄核置換装置市場:医療機器パイプライン分析2016]販売に関する免責事項
★調査レポート[世界の髄核置換装置市場:医療機器パイプライン分析2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆